Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients

[1]  T. Fehm,et al.  HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial , 2010, Breast Cancer Research and Treatment.

[2]  X. Pivot,et al.  Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Goldhirsch,et al.  Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer , 2010, Breast Cancer Research and Treatment.

[5]  M. Loda,et al.  Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer , 2010, British Journal of Cancer.

[6]  T. Fehm,et al.  Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial , 2010, Clinical Cancer Research.

[7]  T. Fehm,et al.  Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point” , 2010, Breast Cancer Research and Treatment.

[8]  T. Fehm,et al.  Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells , 2009, Breast Cancer Research.

[9]  Annibale Biggeri,et al.  Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients , 2009, Breast Cancer Research and Treatment.

[10]  G. Hortobagyi,et al.  Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Kristine Broglio,et al.  Circulating tumor cells in metastatic breast cancer , 2008, Cancer.

[12]  Antonio Eleuteri,et al.  Artificial neural networks estimating survival probability after treatment of choroidal melanoma. , 2008, Ophthalmology.

[13]  P.J.G. Lisboa,et al.  Continuous and Discrete Time Survival Analysis: Neural Network Approaches , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[14]  Leon W M M Terstappen,et al.  Statistical considerations for enumeration of circulating tumor cells , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  F. Cognetti,et al.  HER2/neu role in breast cancer: from a prognostic foe to a predictive friend , 2007, Current opinion in obstetrics & gynecology.

[16]  Brigitte Rack,et al.  Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System , 2007, Clinical Cancer Research.

[17]  Leon W.M.M. Terstappen,et al.  Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.

[18]  G. T. Budd,et al.  Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.

[19]  Douglas G Altman,et al.  Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.

[20]  David Grimes,et al.  Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Alison Stopeck,et al.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  P. Regitnig,et al.  Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer. , 2005, Oncology Report.

[23]  D. Mavroudis,et al.  Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer , 2004, Clinical Cancer Research.

[24]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[25]  Tanja Fehm,et al.  HER-2 gene amplification can be acquired as breast cancer progresses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Lionel Tarassenko,et al.  Non‐linear survival analysis using neural networks , 2004, Statistics in medicine.

[27]  Roberto Tagliaferri,et al.  A novel neural network-based survival analysis model , 2003, Neural Networks.

[28]  W. Vach,et al.  On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. , 2000, Statistics in medicine.

[29]  E Biganzoli,et al.  Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. , 1998, Statistics in medicine.

[30]  E. Baráth,et al.  Fundamentals of Biostatistics. , 1992 .

[31]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[32]  G. Hortobagyi,et al.  Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  V. Valero,et al.  Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.